GBA1 and Parkinson disease: Similar to the genotype–phenotype correlation in GD, clinical studies have highlighted substantial variations in PD symptoms between individuals with mild and severe heterozygous GBA1 mutations (Gan‐Or et al., 2015; Thaler et al., 2018).